1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. SCIENCE 37 HOLDINGS INC

Science 37 Holdings Inc

XNAS: SNCE

Watchlist

Portfolio

Share


Insider Trading disclosures for Science 37 Holdings Inc

The latest disclosure was made by Christine A. Pellizzari in Science 37 Holdings Inc where a trade of 14,579 Common Stock done at an average price of $5.7 was reported to US exchanges on March 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Christine A. Pellizzari Chief Legal and HR Officer 12 Mar 2024 14,579 0 - 5.7 83,829 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 5.75 per share. 12 Mar 2024 35,115 0 - 5.7 201,911 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 37,222 0 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 428 0 - - Earn-Out Right
John W. Hubbard Former Director 12 Mar 2024 2,050 0 - 5.8 11,788 Common Stock
John W. Hubbard Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 20,195 0 - - Stock Option
John W. Hubbard Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 24,742 0 - - Restricted Stock Units
John W. Hubbard Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 2,540 0 - - Earn-Out Right
John W. Hubbard Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 1,378 0 - - Stock Option
Paul von Autenried Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 24,742 0 - - Restricted Stock Units
Paul von Autenried Former Director 12 Mar 2024 2,302 0 - 5.8 13,237 Common Stock
Emily Rollins Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 24,742 0 - - Restricted Stock Units
Emily Rollins Former Director 12 Mar 2024 2,050 0 - 5.8 11,788 Common Stock
Emily Rollins Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 1,378 0 - - Stock Option
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 3,404 0 - - Stock Option
Darcy Forman Chief Delivery Officer 12 Mar 2024 15,753 0 - 5.8 90,580 Common Stock
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 5.75 per share. 12 Mar 2024 24,644 0 - 5.8 141,703 Common Stock
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 28,897 0 - - Restricted Stock Units
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 2,522 0 - - Earn-Out Right
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 4,680 0 - - Stock Option
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 6,807 0 - - Stock Option
David Coman Chief Executive Officer, Former Director Sale or transfer of securities back to the company at price $ 5.75 per share. 12 Mar 2024 30,781 0 - 5.8 176,991 Common Stock
David Coman Chief Executive Officer, Former Director 12 Mar 2024 53,834 0 - 5.8 309,546 Common Stock
David Coman Chief Executive Officer, Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 192,427 0 - - Stock Option
David Coman Chief Executive Officer, Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 28,899 0 - - Earn-Out Right
David Coman Chief Executive Officer, Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 49,512 0 - - Restricted Stock Units
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 6,033 0 - - Earn-Out Right
Mike Zaranek Chief Financial Officer 12 Mar 2024 9,070 0 - 5.8 52,153 Common Stock
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 5.75 per share. 12 Mar 2024 22,212 0 - 5.8 127,719 Common Stock
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 25,621 0 - - Restricted Stock Units
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 45,746 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 5.75 per share. 12 Mar 2024 12,864 0 - 5.8 73,968 Common Stock
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 7,944 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 5,385 0 - - Earn-Out Right
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 23,088 0 - - Restricted Stock Units
Jonathan Cotliar Chief Medical Officer 12 Mar 2024 41,891 0 - 5.7 240,873 Common Stock
Neil Tiwari Former Director 12 Mar 2024 2,050 0 - 5.8 11,788 Common Stock
Neil Tiwari Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 24,742 0 - - Restricted Stock Units
Neil Tiwari Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 1,378 0 - - Stock Option
Robert C. Faulkner Former Director Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2024 2,068 0 - - Stock Options (Right to Buy)
Robert C. Faulkner Former Director 12 Mar 2024 26,791 0 - 5.7 154,048 Common Stock
Michael Shipton Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 10 Mar 2024 52,168 0 - - Restricted Stock Units
Michael Shipton Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2024 8,713 17,426 - - Restricted Stock Units
Michael Shipton Chief Commercial Officer 10 Mar 2024 9,247 0 - 5.7 53,170 Common Stock
Michael Shipton Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.73 per share. 10 Mar 2024 3,006 9,247 - 5.7 17,224 Common Stock
Michael Shipton Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2024 8,713 12,253 - 0 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 355,549 1,076,434 - 0 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 12 Aug 2023 86,577 989,857 - 0.4 38,094 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 355,549 711,097 - - Restricted Stock Units
Darcy Forman Chief Delivery Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 288,972 577,942 - - Restricted Stock Units
Darcy Forman Chief Delivery Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 12 Aug 2023 84,380 807,964 - 0.4 37,127 Common Stock
Darcy Forman Chief Delivery Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 288,972 892,344 - 0 Common Stock
David Coman Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 495,122 1,836,909 - 0 Common Stock
David Coman Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 495,122 990,243 - - Restricted Stock Units
David Coman Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 12 Aug 2023 144,576 1,692,333 - 0.4 63,613 Common Stock
Mike Zaranek Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 256,207 700,490 - 0 Common Stock
Mike Zaranek Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 256,207 512,414 - - Restricted Stock Units
Mike Zaranek Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 12 Aug 2023 74,813 625,677 - 0.4 32,918 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 230,882 1,174,970 - 0 Common Stock
Jonathan Cotliar Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 12 Aug 2023 79,839 1,095,131 - 0.4 35,129 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2023 230,882 461,764 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal and HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 May 2023 16,667 726,499 - 0 Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 May 2023 16,667 33,333 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal and HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 May 2023 5,614 720,885 - 0 Common Stock
John W. Hubbard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 40,983 - 0 Common Stock
John W. Hubbard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 0 - - Restricted Stock Units
John W. Hubbard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Paul von Autenried Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Paul von Autenried Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 46,040 46,040 - 0 Common Stock
Paul von Autenried Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 46,040 0 - - Restricted Stock Units
Robert C. Faulkner Director Grant, award, or other acquisition of securities at price $ 0.25 per share. 11 May 2023 494,853 535,836 - 0.3 125,000 Common Stock
Emily Rollins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 40,983 - 0 Common Stock
Emily Rollins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 0 - - Restricted Stock Units
Emily Rollins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Neil Tiwari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Neil Tiwari Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 40,983 - 0 Common Stock
Neil Tiwari Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 May 2023 40,983 0 - - Restricted Stock Units
Michael Shipton Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Troy Bryenton Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 494,853 494,853 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal and HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 702,332 709,832 - - Common Stock
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 247,000 0 - - Stock Option
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 238,095 0 - - Stock Option
Christine A. Pellizzari Chief Legal and HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 1,270,739 0 - - Stock Option
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 211,538 0 - - Stock Option
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 492,916 603,372 - - Common Stock
Darcy Forman Chief Delivery Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 1,020,754 0 - - Stock Option
David Coman Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 615,650 1,341,787 - - Common Stock
David Coman Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 557,692 0 - - Stock Option
David Coman Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 981,437 0 - - Stock Option
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 467,351 0 - - Stock Option
Mike Zaranek Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 444,283 444,283 - - Common Stock
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 457,466 0 - - Stock Option
Mike Zaranek Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 185,897 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 257,320 944,088 - - Common Stock
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 442,754 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Apr 2023 200,549 0 - - Stock Option
Michael Shipton Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2023 522,793 522,793 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 0.81 per share. 17 Nov 2022 5,000 5,000 - 0.8 4,032 Common Stock
Paul von Autenried Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2022 46,040 46,040 - - Restricted Stock Units
Michael Shipton Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2022 300,000 300,000 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 1,066,646 1,066,646 - - Restricted Stock Units
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 866,914 866,914 - - Restricted Stock Units
David Coman Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 1,485,365 1,485,365 - - Restricted Stock Units
Mike Zaranek Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 768,621 768,621 - - Restricted Stock Units
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 692,646 692,646 - - Restricted Stock Units
Steven Geffon Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 563,414 563,414 - - Restricted Stock Units
Darcy Forman Chief Delivery Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. 29 Jun 2022 68,075 110,456 - 0.3 19,061 Common Stock
Darcy Forman Chief Delivery Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jun 2022 68,075 68,075 - - Stock Option
John W. Hubbard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2022 40,983 40,983 - - Restricted Stock Units
Robert C. Faulkner Director Grant, award, or other acquisition of securities at price $ 3.05 per share. 23 May 2022 40,983 40,983 - 3.0 124,998 Common Stock
Emily Rollins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2022 40,983 40,983 - - Restricted Stock Units
Neil Tiwari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2022 40,983 40,983 - - Restricted Stock Units
Adam Goulburn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2022 40,983 40,983 - - Restricted Stock Units
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 50,000 50,000 - - Restricted Stock Units
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 20 Apr 2022 3,905 630,037 - 0.8 3,319 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Apr 2022 56,731 158,844 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Apr 2022 3,905 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. 20 Apr 2022 56,731 686,768 - 0.4 22,692 Common Stock
Adam Goulburn Director Other type of transaction at price $ 0.00 per share. 04 Apr 2022 2,481 2,481 - 0 Common Stock
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 238,095 238,095 - - Stock Option
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 211,538 211,538 - - Stock Option
David Coman Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 557,692 557,692 - - Stock Option
Mike Zaranek Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 185,897 185,897 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 200,549 200,549 - - Stock Option
Steven Geffon Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 211,538 211,538 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 25 Oct 2021 5,857 545,736 - 0.8 4,978 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 11,345 215,575 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 25 Oct 2021 4,538 539,879 - 0.8 3,857 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 977 3,905 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 68,074 226,920 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 5,857 4,882 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 4,538 0 - - Stock Option
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. 25 Oct 2021 11,345 626,132 - 0.4 4,538 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 25 Oct 2021 977 614,787 - 0.8 830 Common Stock
Jonathan Cotliar Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. 25 Oct 2021 68,074 613,810 - 0.4 27,230 Common Stock
Robert C. Faulkner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 41,363 41,363 - - Stock Option (Right to Buy)
Emily Rollins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 27,575 27,575 - - Stock Option
Adam Goulburn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 27,575 27,575 - - Stock Option
Neil Tiwari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 27,575 27,575 - - Stock Option
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 8,541 8,541 - - Earn-Out Right
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 247,000 247,000 - - Stock Option
John W. Hubbard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 27,575 27,575 - - Stock Option
John W. Hubbard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 50,802 50,802 - - Earn-Out Right
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 50,428 50,428 - - Earn-Out Right
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 1,020,754 1,020,754 - - Stock Option
David Coman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 577,984 577,984 - - Earn-Out Right
David Coman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 981,437 981,437 - - Stock Option
Mike Zaranek Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 120,644 120,644 - - Earn-Out Right
Mike Zaranek Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 467,351 467,351 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 442,754 442,754 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 107,692 107,692 - - Earn-Out Right
Steven Geffon Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 115,079 115,079 - - Earn-Out Right
Steven Geffon Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 1,017,351 1,017,351 - - Stock Option
Christine A. Pellizzari Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 1,270,710 1,270,710 - - Stock Option
John W. Hubbard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 403,896 403,896 - - Stock Option
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 136,147 136,147 - - Stock Option
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 42,381 42,381 - - Common Stock
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 93,602 93,602 - - Stock Option
Darcy Forman Chief Delivery Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 136,147 136,147 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 533,264 533,264 - - Common Stock
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 4,538 4,538 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 10,739 10,739 - - Stock Option
Jonathan Cotliar Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 294,986 294,986 - - Stock Option
Steven Geffon Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 914,916 914,916 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters